ArticleFrontiers in immunology2025

Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.

Xiaohui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.